Defense World
15 Nov 2025, 08:44 UTC · 42w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
1 claim · each scored for market impact
Phathom Pharmaceuticals has an average brokerage recommendation of 'Moderate Buy' based on seven analysts. — General analyst consensus provides a mild positive sentiment signal but lacks a catalyst for significant price movement.
+0.20Which stocks this story touches
The company has received a 'Moderate Buy' average recommendation from brokerages, with a majority of analysts rating the stock as a buy.
Continue reading
5 related stories
Search tags
Read next
PRNewsWire · 14h ago
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
17h ago
